Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. Terms of Market Authorization
  4. Information about controlled substance advertising regulations
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

Information about controlled substance advertising regulations

Scheduled Pinned Locked Moved Terms of Market Authorization
2 Posts 2 Posters 470 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • G Offline
    G Offline
    gbrl88
    wrote on last edited by
    #1

    Hi PAAB, what are some good resources to learn more about discussing controlled substances with HCPs including promo, rep activities, sampling, etc?

    Jennifer CarrollJ 1 Reply Last reply
    0
    • G gbrl88

      Hi PAAB, what are some good resources to learn more about discussing controlled substances with HCPs including promo, rep activities, sampling, etc?

      Jennifer CarrollJ Offline
      Jennifer CarrollJ Offline
      Jennifer Carroll
      wrote on last edited by
      #2

      Hello @gbrl88 ,
      We’ll begin by reiterating that promotion of these products to the public is strictly prohibited. Now onto your question. With regards to HCP advertising, the provisions of the PAAB Code apply to all healthcare products including narcotics and controlled drugs.

      The Food and Drugs Act, the Food and Drug Regulations, the Controlled Drugs and Substances Act, and the Narcotic Control Regulations outline Federal requirements pertaining to promotional materials and promotional activities (including sampling). Note that provinces may also impose additional local restrictions pertaining to sampling activities. The Innovative Medicines Canada Code of Ethical Practices also contains standards pertaining to the activity of sampling.
      You may have heard that Health Canada has recently amended healthcare product sampling laws. These amendments came into effect on July 1, 2020. But they do NOT impact sampling pertaining to controlled drugs.

      Importantly, for opioids (specifically those on Part B of the Opioids list), Health Canada has established Terms and Conditions that must be adhered. This was followed by additional restrictions on marketing of opioids.

      Does anyone in this community use additional resources pertaining to the question? If so, sharing is caring! Post them in this thread.

      1 Reply Last reply
      0
      Reply
      • Reply as topic
      Log in to reply
      • Oldest to Newest
      • Newest to Oldest
      • Most Votes


      • Login

      • Don't have an account? Register

      • Login or register to search.
      • First post
        Last post
      0
      • Categories
      • Recent
      • Tags
      • Popular
      • Users
      • Groups